John T. Vetto

9.6k total citations · 1 hit paper
164 papers, 6.8k citations indexed

About

John T. Vetto is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, John T. Vetto has authored 164 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Oncology, 33 papers in Molecular Biology and 32 papers in Epidemiology. Recurrent topics in John T. Vetto's work include Cutaneous Melanoma Detection and Management (58 papers), CAR-T cell therapy research (23 papers) and Nonmelanoma Skin Cancer Studies (23 papers). John T. Vetto is often cited by papers focused on Cutaneous Melanoma Detection and Management (58 papers), CAR-T cell therapy research (23 papers) and Nonmelanoma Skin Cancer Studies (23 papers). John T. Vetto collaborates with scholars based in United States, Israel and Japan. John T. Vetto's co-authors include Steven A. Rosenberg, Michael T. Lotze, Alfred E. Chang, Stephen E. Ettinghausen, Claudia A. Seipp, Yvedt L. Matory, Eitan Shiloni, Linda Muul, Susan F. Leitman and Colleen Simpson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

John T. Vetto

158 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

1985 2.0k citations John T. Vetto et al. profile →

Peers

Countries citing papers authored by John T. Vetto

Since Specialization

Citations

This map shows the geographic impact of John T. Vetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Vetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Vetto more than expected).

Fields of papers citing papers by John T. Vetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Vetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Vetto. The network helps show where John T. Vetto may publish in the future.

Co-authorship network of co-authors of John T. Vetto

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Vetto. A scholar is included among the top collaborators of John T. Vetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Vetto. John T. Vetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma 2025 ·Annals of Surgical Oncology ·Nazia Riaz, Anne Huibers, Stanley P. L. Leong, Mohammed Kashani–Sabet, R. L. White, John T. Vetto, Schlomo Schneebaum, Cristina O’Donoghue, H. J. Howard, Eli Avisar, Jukes P. Namm, Heidi Kosiorek, Barbara A. Pockaj, Mark B. Faries, Giorgos C. Karakousis, Jonathan S. Zager, Roger Olofsson Bagge	1
2	Real World Experience of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program: primary referral to TIL infusion (Brain to Vein) 2025 ·Cytotherapy ·Amrita Desai, Cristian D. Valenzuela, Brandon Hayes‐Lattin, (unknown), Aimee D. Kohn, (unknown), Bashi Ratterree, Staci Williamson, R.K. Knight, Gabrielle Meyers, John T. Vetto, Richard T. Maziarz	1
3	Is the presence of tumor‐infiltrating lymphocytes predictive of outcomes in patients with melanoma? 2022 ·Cancer ·(unknown), Gang Han, (unknown), John T. Vetto, Graham Fowler, Stanley P. L. Leong, Mohammed Kashani–Sabet, Barbara A. Pockaj, Heidi Kosiorek, Jonathan S. Zager, Vernon K. Sondak, Jane L. Messina, Nicola Mozzillo, Schlomo Schneebaum, Dale Han, (unknown)	3
4	Clinical Utility of Dermoscopy and 31-Gene Expression Profiling by Dermatology Providers in Melanoma Management Care 2022 ·Journal of Drugs in Dermatology ·Alexander Witkowski, Claudia Lee, Emile Latour, John T. Vetto, Joanna Łudzik	0
5	Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis 2021 ·Cancer Control ·(unknown), Gerardo A. Vitiello, Erica B. Friedman, James Sun, (unknown), (unknown), Norma E. Farrow, Clara R. Farley, John T. Vetto, Dale Han, (unknown), Georgia M. Beasley, Carlo M. Contreras, Michael Lowe, Jonathan S. Zager, Iman Osman, Russell S. Berman, Tracey N. Liebman, Jennifer Stein, Ann Y. Lee	16
6	Relationship of patient age to tumor factors and outcomes among patients undergoing sentinel node biopsy for melanoma 2020 ·The American Journal of Surgery ·(unknown), Dale Han, Graham Fowler, Gang Han, (unknown), John T. Vetto	6
7	Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit 2019 ·Journal of Surgical Oncology ·Nicholas D. Klemen, Gang Han, Stanley P. L. Leong, Mohammed Kashani–Sabet, John T. Vetto, Richard L. White, Schlomo Schneebaum, Barbara A. Pockaj, Nicola Mozzillo, Kim Charney, Harald J. Hoekstra, Vernon K. Sondak, Jane L. Messina, Jonathan S. Zager, Dale Han	12
8	Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program 2019 ·The American Journal of Surgery ·Shushan Rana, Arpana Naik, (unknown), John T. Vetto, Rodney F. Pommier, Charlotte Dai Kubicky	8
9	Stratifying SLN incidence in intermediate thickness melanoma patients 2017 ·The American Journal of Surgery ·James M. Chang, Heidi Kosiorek, Amylou C. Dueck, Stanley P. L. Leong, John T. Vetto, Richard L. White, Eli Avisar, Vernon K. Sondak, Jane L. Messina, Jonathan S. Zager, Carlos A. Garberoglio, Mohammed Kashani–Sabet, Barbara A. Pockaj	21
10	Is pelvic sentinel node biopsy necessary for lower extremity and trunk melanomas? 2017 ·The American Journal of Surgery ·Darryl Schuitevoerder, Stanley P. L. Leong, Jonathan S. Zager, Richard L. White, Eli Avisar, Heidi Kosiorek, Amylou C. Dueck, (unknown), Mohammed Kashani–Sabet, Kyle D. Hart, John T. Vetto	4
11	Axillary web syndrome: an underappreciated complication of sentinel node biopsy in melanoma 2016 ·The American Journal of Surgery ·Darryl Schuitevoerder, Ian White, (unknown), John T. Vetto	10
12	Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy 2015 ·Cancer Prevention Research ·(unknown), Zhenzhen Zhang, Motomi Mori, Paige E. Farris, John T. Vetto, Arpana Naik, Karen Y. Oh, Philippe Thuillier, Emily Ho, Jackilen Shannon	104
13	Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma 2013 ·Journal of Clinical Oncology ·Dale Han, Jonathan S. Zager, Yu Shyr, Heidi Chen, Lynne D. Berry, Sanjana Iyengar, Mia Djulbegovic, (unknown), Suroosh S. Marzban, Vernon K. Sondak, Jane L. Messina, John T. Vetto, Richard L. White, Barbara A. Pockaj, Nicola Mozzillo, Kim Charney, Eli Avisar, Robert S. Krouse, Mohammed Kashani–Sabet, Stanley P. L. Leong	161
14	Factors influencing accuracy of axillary sentinel lymph node frozen section for breast cancer 2010 ·The American Journal of Surgery ·(unknown), Arpana Naik, Rodney F. Pommier, John T. Vetto, Megan L. Troxell	39
15	Gastric malignancies in breast cancer survivors: Pathology and outcomes 2009 ·The American Journal of Surgery ·(unknown), (unknown), (unknown), (unknown), John T. Vetto	10
16	Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs) 2009 ·OncoTargets and Therapy ·John T. Vetto	6
17	Vitreo-retinal traction and anastrozole use 2008 ·Breast Cancer Research and Treatment ·Alvin Eisner, Emily J. Thielman, Julie Falardeau, John T. Vetto	23
18	Breast cancer severity score is an innovative system for prognosis 2003 ·The American Journal of Surgery ·(unknown), Bruce Ham, John T. Vetto, Rodney F. Pommier	9
19	Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity 2000 ·The Journal of Immunology ·Andrew D. Weinberg, (unknown), Rodney A. Prell, Arden M. Morris, (unknown), John T. Vetto, Walter J. Urba, Gregory Alvord, Campbell Bunce, John Shields	315
20	Cirsoid Aneurysms of the Jejunum 1989 ·Archives of Surgery ·John T. Vetto	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact